Important Announcements

ACL Laboratories continuously strives to provide the best laboratory services possible. Our Test Bulletins and Important Announcements include information regarding new test offerings, changes in test procedures, reference range changes, or modifications in specimen collection protocol and/or new specimen collection devices.

jun. 25, 2026

ACL Launches AdvoOnc Hereditary Cancer Testing 7.1.2026

Effective Wednesday, July 1, 2026, ACL Laboratories will begin performing hereditary cancer genetic testing. Read announcement for more details. Read more

jun. 25, 2026

ACL Respiratory Pathogens Data June 20, 2026

Posted by Eric Beck. Read more

jun. 20, 2026

ACL June 2026 Test Bulletin

ACL Announces Launch of AdvoOncTM Hereditary Cancer Testing -- ACL Laboratories Discontinues Culturing of Intravascular Catheters -- Temporary Referral of High-Sensitivity C-Reactive Protein -- ACL Laboratories Transitions Ceruloplasmin (Test Order Code LAB8512) -- New Orderable Code: AML - FLT3 ITD MRD by NGS -- Beta – Trace Protein, Body Fluid … Read more

jun. 17, 2026

ACL Respiratory Pathogens Data June 13, 2026

Posted by Eric Beck Read more

jun. 10, 2026

ACL Respiratory Pathogens Data June 6, 2026

Posted by Eric Beck Read more